Category:

Eco/Invest/Demography

Latest

UK’s Boris Johnson launches mass testing programme as economy reopens

Johnson, who is expected to confirm plans to relaunch international travel and open sections of the economy later on Monday, said the new mass testing programme would break the chain of transmissions and spot cases without symptoms
Vaccine passports are also being trial led for mass events.

Under the current plan international travel will not resume until May 17 at the earliest.

read more

Covid-19 affecting children more than in first wave, says paediatrician

“The second wave of Covid is known to affect the children much more than in the first wave. Also, a reverse trend is being seen that is – children develop symptoms first, and then adults are getting it from them. The difference is while in the first wave most of the children were asymptomatic, in the second wave they are coming with symptoms like fever, cold, dry cough, loose motions, vomiting, not feeding well, fatigue, loss of appetite, among other common symptoms. Few may also have breathing difficulties and rashes like any other viral fever,” he said.

read more

Facebook admits leaked data on 533 million users back online for free

The leak includes personal information on 533 million Facebook users, such as phone numbers, Facebook IDs, full names, locations, birth dates, bios and in some cases email addresses, Business Insider reported.

At the time, the company addressed a flaw in its technology that allowed the information to leak out. However, once such data escapes from Facebook’s network, the company has limited power to stop it from spreading online.

read more

World economy risks ‘dangerously diverging’ even as growth booms

For the year as whole, Bloomberg Economics forecasts growth of 6.9%, the quickest in records dating back to the 1960s. Behind the buoyant outlook: a shrinking virus threat, expanding US stimulus, and trillions of dollars in pent-up savings.

Much will depend on how fast countries can inoculate their populations with the risk that the longer it takes the greater the chance the virus remains an international threat especially if new variants develop. Bloomberg’s Vaccine Tracker shows while the US has administered doses equivalent to almost a quarter of its people, the European Union has yet to hit 10% and rates in Mexico, Russia and Brazil are less than 6%.

read more